Acute kidney injury (AKI) remains a commonly encountered medical problem, often fi nding its way to the intensive care unit (ICU). Treatment involves normalisation of the circulation, and, failing that, renal replacement therapy (RRT) of whatever type.
including fewer patients [2, 3] . Moreover, the data share similarities with several subsequent scoring systems for AKI -namely, age, need for ventilation, oligo-anuria, liver dysfunction and acidosis [4, 5] .
What should be borne in mind is that the data analysed are somewhat old, and that over this period there have been several changes in the ICU practice for RRT: not least in the choice of replacement fl uid and the dosing of RRT. Bicarbonate-buff ered haemofi ltration was not described until 1991 and was not commercially available until the late 1990s. In addition, dosing of RRT has gradually increased during the past decade, and it is likely in the present study that the dose may have been inadequate, particularly in the patients receiving continuous arteriovenous techniques. Using the current buff ering techniques and RRT dose, therefore, the observed eff ects on acid-base parameters may not be so marked.
In medicine, much like politics, one of the essential ingredients is timing; however, there is only a small evidence base regarding the time to initiate RRT in AKI [6] . In Ostermann and Chang's study, mortality was signifi cantly lower when RRT was started before the AKI stage III creatinine criteria were fulfi lled (serum creatinine ≤354 μmol/l or a rise in serum creatinine by >300% from baseline), and also when RRT was started <3 days after ICU admission [1] . Although these fi ndings may suggest that early initiation of RRT is benefi cial, the retrospective design of this study does not allow defi nitive conclusions that may directly infl uence practice to be drawn. Only one randomised controlled trial has so far investigated whether the timing of RRT improves outcome in a mixed ICU population with AKI, and the results were inconclusive [7] . A recent systematic review identifi ed 23 studies on the timing of RRT, including 10 studies more than 30 years ago, and a subse quent meta-analysis suggested that early initiation of RRT may improve outcome [8] . Th e methodological quality of the trials favouring early timing is poor, however, and the studies cannot be sensibly combined in a meta-analysis because of the heterogeneity in the defi nitions of timing, study populations and RRT techniques.
Several important questions therefore remain when considering RRT for AKI -namely, when to start treatment, how long to continue treatment and, to a degree, how much treatment to give. Th e answers to these questions will probably involve not only renal criteria, but also the severity of other organ failure(s). Although we do need properly designed randomised controlled trials to answer these questions, the identifi cation of risk factors for death following AKI may help in the design of future studies as well as, perhaps, the use of biomarkers. Th e con ventional renal criteria (creatinine and diuresis) are a poor refl ection of AKI and do not diff erentiate between pre-renal failure and intrinsic renal damage. Early initiation of RRT in pre-renal failure is probably less impor tant given that it is likely to recover after resuscitation of the circulation. If AKI is the result of cellular injury due to ischemia, reperfusion, infl am mation or oxidant stress, however, early initiation may mitigate further damage. Th e use of biomarkers may prove helpful to detect AKI at an early stage, to diff er en tiate pre-renal failure from AKI, and to decide when to start or stop RRT [9] . We shall have to wait and see.
